Specialty × MAC Jurisdiction Intelligence
EndocrinologyCMS & MAC AlertsWPS Government Health Administrators · Jurisdictions J5, J8
Every CMS transmittal, WPS Government Health Administrators LCD revision, Federal Register notice, and OIG alert affecting Endocrinology billing teams in Indiana, Iowa, Kansas, Michigan, Missouri, Nebraska. Signal-scored and updated daily.
Active alerts
12
Critical / High
2
MAC jurisdiction
J5, J8
Highest-risk CPT
CPT 99213
Recent Endocrinology alerts under WPS Government Health Administrators
2 of the 12 most recent Endocrinology reimbursement alerts are Critical/High-severity for WPS Government Health Administrators (Jurisdictions J5, J8) billing teams. Each links to the source CMS/MAC document with the codes to review and the action to take.
- FDA Approval: MOUNJARO (TIRZEPATIDE) — Type 1 - New Molecular EntitySep 3, 2026
- FDA Approval: ZEPBOUND (TIRZEPATIDE) — Type 10 - New Indication Submitted as Distinct NDA - Not ConsolidatedAug 28, 2026
- FDA Approval: SYNJARDY (EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) — Type 4 - New CombinationAug 14, 2026
- FDA Approval: KAZANO (ALOGLIPTIN AND METFORMIN HYDROCHLORIDE) — Type 4 - New CombinationAug 14, 2026
- FDA Approval: SEGLUROMET (ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE) — Type 4 - New CombinationAug 14, 2026
- FDA Approval: JENTADUETO XR (LINAGLIPTIN AND METFORMIN HYDROCHLORIDE) — Type 4 - New CombinationAug 14, 2026
- FDA Approval: JANUMET XR (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) — Type 3 - New Dosage FormAug 14, 2026
- FDA Approval: FORTAMET (METFORMIN HYDROCHLORIDE) — Type 5 - New Formulation or New ManufacturerAug 14, 2026
- FDA Approval: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) — Type 4 - New CombinationAug 14, 2026
- FDA Approval: SYNJARDY XR (EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE) — Type 3 - New Dosage FormAug 14, 2026
- FDA Approval: ACTOPLUS MET (PIOGLITAZONE AND METFORMIN HYDROCHLORIDE) — Type 4 - New CombinationAug 14, 2026
- FDA Approval: INVOKAMET (CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) — Type 4 - New CombinationAug 14, 2026
Signal intelligence — Endocrinology × WPS Government Health Administrators
Highest-risk CPT code
CPT 99213
Office visit, established patient, low complexity
View full CPT alert profileWPS Government Health Administrators jurisdiction
J5, J8
Covers Indiana, Iowa, Kansas, Michigan, Missouri, Nebraska. Every endocrinology LCD revision, CMS transmittal, and Federal Register notice affecting these states is signal-scored and surfaced here daily.
View all 12 active alerts for Endocrinology under WPS Government Health Administrators
Full alert text, action recommendations, effective date deadlines, MAC LCD links, and signal score rationale — updated daily.
About WPS Government Health Administrators (Jurisdictions J5, J8)
WPS Government Health Administrators is the Medicare Administrative Contractor responsible for processing Medicare Part A and Part B claims in Jurisdictions J5, J8, covering Indiana, Iowa, Kansas, Michigan, Missouri, Nebraska.WPS Government Health Administrators issues Local Coverage Determinations (LCDs) that define coverage criteria, ICD-10-CM diagnosis code requirements, and CPT billing guidelines for Endocrinology procedures within its jurisdiction. CLV Intelligence monitors WPS Government Health Administrators's LCD publication feed, provider bulletin archives, and CMS contractor-specific transmittals daily.
Endocrinology alerts in other MAC jurisdictions
Get weekly Endocrinology alerts for WPS Government Health Administrators — free
No credit card required. Unsubscribe any time.
Frequently asked
- What are the recent CMS updates for Endocrinology under WPS Government Health Administrators MAC?
- According to CLV Intelligence data, updated September 3, 2026, there are currently 12 active CMS and MAC reimbursement policy alerts for Endocrinology under WPS Government Health Administrators (Jurisdictions J5, J8). Of these, 2 are classified Critical or High priority based on signal scoring of source authority, effective-date urgency, and document type. Alerts originate from WPS Government Health Administrators Local Coverage Determinations (LCDs), CMS transmittals, Federal Register proposed and final rules, and OIG compliance publications. CLV Intelligence monitors all WPS Government Health Administrators publications daily and assigns a signal score (0–100) to surface the changes most likely to affect coding accuracy and reimbursement.
- How many active audit alerts exist for Endocrinology CPT codes under WPS Government Health Administrators?
- According to CLV Intelligence data, 12 active reimbursement and policy alerts currently affect Endocrinology CPT codes monitored under WPS Government Health Administrators (Jurisdictions J5, J8). 2 of these alerts carry a Critical or High signal score, indicating elevated compliance risk or near-term effective dates requiring timely coding review. The highest-risk CPT code currently flagged in the Endocrinology alert set is CPT 99213 (Office visit, established patient, low complexity), which appears in WPS Government Health Administrators LCD and CMS billing guidance revisions. CLV Intelligence cross-references each alert against the HCPCS and CPT code sets to surface procedure-level exposure for Endocrinology billing teams.
- Which MAC jurisdiction covers Endocrinology billing for practices in the WPS Government Health Administrators region?
- WPS Government Health Administrators administers Medicare Part A and Part B claims for practices in Jurisdictions J5, J8. For Endocrinology providers, WPS Government Health Administrators issues Local Coverage Determinations (LCDs) that define coverage criteria, billing requirements, ICD-10-CM diagnosis code ranges, and CPT procedure code guidelines applicable to Medicare claims in its jurisdiction. According to CLV Intelligence data, WPS Government Health Administrators monitors 12 open Endocrinology alerts as of September 3, 2026. Practices in the WPS Government Health Administrators jurisdiction should monitor LCD revisions at WPS Government Health Administrators's provider portal and through aggregated daily alerting services such as CLV Intelligence.
- Is CPT 99213 currently under CMS or MAC review for Endocrinology?
- According to CLV Intelligence data, CPT 99213 (Office visit, established patient, low complexity) is currently flagged as a high-signal procedure code within the Endocrinology alert set monitored under WPS Government Health Administrators (Jurisdictions J5, J8). CMS and MAC contractors regularly review high-volume procedure codes for coverage criteria changes, NCCI edit revisions, medical necessity documentation requirements, and fee schedule adjustments. CLV Intelligence assigns CPT 99213 an elevated signal score based on the volume and recency of policy documents referencing this code. Endocrinology coding teams should review the latest WPS Government Health Administrators LCD and CMS transmittals affecting CPT 99213 before claim submission to avoid denials or post-payment audits.